首页 | 本学科首页   官方微博 | 高级检索  
检索        

2012-2016年西安市第一医院质子泵抑制剂的使用情况分析
引用本文:陈敏,陈波.2012-2016年西安市第一医院质子泵抑制剂的使用情况分析[J].现代药物与临床,2017,32(12):2511-2517.
作者姓名:陈敏  陈波
作者单位:西安市第一医院 药学部, 陕西 西安 710002,西安市北方医院, 陕西 西安 710043
摘    要:目的 对2012-2016年西安市第一医院质子泵抑制剂(PPIs)的使用情况进行分析,为临床合理用药提供参考。方法 采用回顾性方法,对2012-2016年西安市第一医院PPIs的销售金额、用药频度(DDDs)、日均费用(DDC)和排序比(B/A)等进行统计分析。结果 2012-2016年,PPIs的销售金额呈逐年增长的趋势;门诊和住院患者PPIs的销售金额、DDDs整体呈增加趋势;口服PPIs的销售金额和DDDs分别占24.4%、71.3%;注射用PPIs的销售金额和DDDs占比分别为75.6%、28.7%;5年来销售金额排名前3位的是注射用泮托拉唑(40 mg)、注射用兰索拉唑和雷贝拉唑钠肠溶片;DDDs排名前3位的是兰索拉唑肠溶片、雷贝拉唑钠肠溶片和注射用泮托拉唑(40 mg)。奥美拉唑肠溶胶囊、兰索拉唑肠溶片和泮托拉唑肠溶胶囊的DDC在5年中均小于10元。注射用兰索拉唑和注射用泮托拉唑(40 mg)5年的B/A均小于1.00。消化科PPIs的用药金额始终为第1位。结论 西安市第一医院注射用泮托拉唑的用量相对较大,可能存在一定程度的过度用药和不合理用药。

关 键 词:质子泵抑制剂  用药频度  限定日费用  合理用药
收稿时间:2017/7/31 0:00:00

Analysis on the application of proton pump inhibitors in Xi'an No. 1 Hospital from 2012 to 2016
CHEN Min and CHEN Bo.Analysis on the application of proton pump inhibitors in Xi'an No. 1 Hospital from 2012 to 2016[J].Drugs & Clinic,2017,32(12):2511-2517.
Authors:CHEN Min and CHEN Bo
Institution:Department of Pharmacy, Xi''an No.1 Hospital, Xi''an 710002, China and Xi''an North Hospital, Xi''an 710043, China
Abstract:Objective To analyze the application of proton pump inhibitors (PPIs) in Xi''an No. 1 Hospital from 2012 to 2016, and in order to provide reference for clinical rational use of drugs. Methods A retrospective survey was conducted to analyze consumption sum, frequency of drug use (DDDs), defined daily cost (DDC), and sequence ratio (B/A) of PPIs in Xi''an No. 1 Hospital from 2012 to 2016. Results Consumption sum of PPIs increased year by year from 2012 to 2016. Consumption sum and DDDs of outpatient and inpatient had a tendency of increase on the whole. Consumption sum and DDDs of oral PPIs accounted for 24.4% and 71.3%, while those of PPIs for injection accounted for 75.6% and 28.7%. The top three drugs in the list of consumption sum in 5 years were Pantoprazole for injection (40 mg), Lansoprazole for injection, and Rabeprazole Sodium Enteric-coated Tablets. DDDs of Lansoprazole Tablets, Pantoprazole for injection, and Rabeprazole Sodium Enteric-coated Tablets ranked top three. DDC of Omeprazole Enteric-coated Capsules, Lansoprazole Enteric-coated Tablets, and Pantoprazole Sodium Enteric-Coated Capsules in 5 years were lower than 10. B/A of Lansoprazole for injection and Pantoprazole for injection (40 mg) in 5 years were less than 1.00. Consumption sum of PPIs in Department of Gastroenterology ranked the first. Conclusion The usage of Lansoprazole for injection in Xi''an No. 1 Hospital is relatively large, and it may be some degree of excessive use and irrational use.
Keywords:proton pump inhibitors  frequency of drug use  defined daily cost  rational drug use
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号